Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P250019/S003

SAPIEN M3 Transcatheter Mitral Valve Replacement System

Edwards Lifesciences, LLC · Decision date Apr 16, 2026

FDA DECISIONP250019/S003

What did the FDA decide?

FDA records P250019/S003 as a supplement to PMA P250019, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Apr 16, 2026.

FDA approval order statement

an alternative method to process devices prior to RESILIA treatment, and cleanroom modifications to accommodate this alternative processing method
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Apr 16, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P250019/S003
Regulatory pathway
PMA supplement
Product code
NPU
Decision code
OK30
Decision date
Apr 16, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, mitral valve, percutaneously delivered.

Product code
NPU
FDA device class
3

For the original device and its historical approval scope, see PMA P250019. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P250019 · Original PMA

    SAPIEN M3 Transcatheter Mitral Valve Replacement System

  2. P250019/S001 · Related supplement

    SAPIEN M3 Transcatheter Mitral Valve Replacement System

  3. P250019/S002 · Related supplement

    Edwards SAPIEN M3 Transcatheter Heart Valve (sizes 20mm, 23mm, 26mm, 29mm)

  4. P250019/S003 received

    Application receipt date recorded by FDA.

  5. P250019/S003 · FDA decision

    30-Day Notice

  6. P250019/S005 · Related supplement

    SAPIEN M3 Transcatheter Heart Valve (9880TFX29M)

  7. P250019/S006 · Related supplement

    Edwards SAPIEN M3 Dock (988DDS); Edwards 23F Guide Sheath (9880GS); Edwards SAPIEN M3 Crimper (9880CR); Edwards Commande

Timeline entries are records held by MedtechLedger for P250019. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250019

Explore the linked device profile

Other records with product code NPU

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementAug 31, 2026FDA
ABBOTT MEDICALPMA supplementAug 7, 2026FDA
ABBOTT MEDICALPMA supplementOct 4, 2025FDA
ABBOTT MEDICALPMA supplementJul 29, 2025FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records